NYSE : DVA
DaVita Inc. — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 187.5 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 11.80B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 11.80B |
| Enterprise Value | 24.62B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 62.92M |
| Shares Outstanding | 62.92M |
| Shares Change (YoY) | -14.08% |
| Shares Change (QoQ) | -0.89% |
| Owned by Insiders (%) | 1.77% |
| Owned by Institutions (%) | 48.50% |
| Float | 33.45M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 13.84 |
| Forward PE | 11.67 |
| PS Ratio | 0.83 |
| Forward PS | 0.82 |
| PB Ratio | 10.48 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.12 |
| P/OCF Ratio | 6.31 |
| PEG Ratio | 0.44 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 26.76 |
| EV / Sales | 1.74 |
| EV / EBITDA | 8.65 |
| EV / EBIT | 11.46 |
| EV / FCF | 19.03 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.41 |
| Quick Ratio | 1.28 |
| Debt / Equity | 11.90 |
| Debt / EBITDA | 3.76 |
| Debt / FCF | 10.35 |
| Interest Coverage | 3.72 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 96.79% |
| Return on Assets (ROA) | 7.59% |
| Return on Invested Capital (ROIC) | 12.18% |
| Return on Capital Employed (ROCE) | 14.39% |
| Weighted Average Cost of Capital (WACC) | 5.84% |
| Revenue Per Employee | $181,635 |
| Profits Per Employee | $11,796 |
| Employee Count | 78,000 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 63.85 |
Taxes
| Measure | Value |
|---|
| Income Tax | 324.03M |
| Effective Tax Rate | 21.35% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.80 |
| 52-Week Price Change | +48.15% |
| 50-Day Moving Average | 181.40 |
| 200-Day Moving Average | 177.01 |
| Relative Strength Index (RSI) | 54.33 |
| Average Volume (20 Days) | 773,364 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4.91M |
| Short Previous Month | 4.30M |
| Short % of Shares Out | 7.80% |
| Short % of Float | 14.67% |
| Short Ratio (days to cover) | 7.53 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 14.17B |
| Gross Profit | 4.57B |
| Operating Income | 2.15B |
| Pretax Income | 1.52B |
| Net Income | 920.08M |
| EBITDA | 2.85B |
| EBIT | 2.15B |
| Earnings Per Share (EPS) | $13.55 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 566.30M |
| Total Debt | 13.39B |
| Net Cash | -12.83B |
| Net Cash Per Share | -$203.84 |
| Equity (Book Value) | 1.13B |
| Book Value Per Share | -9.32 |
| Working Capital | 1.19B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 1.87B |
| Capital Expenditures | -576.75M |
| Depreciation & Amortization | 697.53M |
| Net Borrowing | 522.31M |
| Free Cash Flow | 1.29B |
| FCF Per Share | $20.56 |
Margins
| Measure | Value |
|---|
| Gross Margin | 32.28% |
| Operating Margin | 15.17% |
| Pretax Margin | 10.71% |
| Profit Margin | 6.49% |
| EBITDA Margin | 20.09% |
| EBIT Margin | 15.17% |
| FCF Margin | 9.13% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 14.08% |
| Shareholder Yield | 14.08% |
| Earnings Yield | 7.23% |
| FCF Yield | 10.97% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $218.71 |
| Price Target Difference | 16.65% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 3.77% |
| EPS Growth Forecast (3Y) | 23.07% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Sep 9, 2013 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.68 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |